Weekending:- 06-03-2020 Legal Publication Date:- 09-07 ... · Legal Publication Date:- 09-07-2020 Journal Code (200709) Patents’ journal 09-07-2020 1 NEW APPLICATIONS FOR THE PATENTS

Electronic Publication of Patents Journal

under The Patents (Amendments) Act, 2016

Weekending:- 06-03-2020

Legal Publication Date:- 09-07-2020

Journal Code (200709)

Patents’ journal 09-07-2020

1

NEW APPLICATIONS FOR THE PATENTS

The dates shown in the crescent brackets are the dates claimed under section 86 of the Patents

Ordinance 2000.

02/03/2020

142/2020

Prothena Biosciences Limited, Ireland.

(Priority 03/03/2019 US; 03/03/2019

US)

“Antibodies Recognizing Tau”

03/03/2020

143/2020

Meiji Co., Ltd., Japan

(Priority 04/03/2019 JP)

“METHOD FOR PRODUCING POWDER COMPRESSED ITEM”

144/2020

CASALE SA, Switzerland.

(Priority 05/03/2019 EP)

“A METHOD FOR THE SUPPRESSION OF SOOT FORMATION IN AN ATR OR POX REACTOR”

145/2020



“METHOD FOR REVAMPING A CATALYTIC CONVERTER”

146/2020

Eisai R&D Management Co., Ltd. Japan.


“PENTACYCLIC HETEROCYCLES”

147/2020

Nouman Idris Butt, and Mrs. Michiko Yoshida (Mariam Siddiqa) Pakistan.

“A CONTROLLED REBOUND THERMO-DYNAMIC BALL AND METHOD OF MANUFACTURING OF THE SAME”

148/2020

Muhammad Zayyan Usmani. Pakistan.

“a robot that can cook food”

149/2020

Dr. Farhat Yasmeen; Aqsa Ahmed; Farzeen Sheikh and Dr. Humayun Ijaz Pakistan.

“Formulation of Binyl radiative cooling coating for energy-efficient buildings, vehicles and clothing”


2

150/2020

AstraZeneca AB. Sweden.

(Priority 05/03/2019 US)

“FUSED TRICYCLE COMPOUNDS”

04/03/2020

151/2020

Muhammad Arshad. Pakistan.

“Disco Naan”

152/2020

Corn Products Development, Inc. U.S.A.


“Steviol Glycoside Compositions with Improve Solubility”

153/2020

GlaxoSmithKline Intellectual Property (No.2) Limited and ViiV Healthcare Company. U.S.A.


“COMPOUNDS USEFUL IN HIV THERAPY”

05/03/2020

154/2020

BAYER OY. Finland.


“SOUND APPLICATOR”

06/03/2020

155/2020

Graf + Cie AG, Switzerland.

(Priority 25/03/2019 CH)

“Circular comb for a combing machine”

156/2020

JVC KENWOOD Corporation. Japan.


“ PICTURE CODING DEVICE, MOVING PICTURE CODING METHOD, MOVING PICTURE CODING PROGRAM, MOVING PICTURE DECODING DEVICE, MOVING PICTURE DECODING METHOD, AND MOVING PICTURE DECODING PROGRAM”

157/2020

Anglo American Services (UK) Ltd, United Kingdom.


“Tailings Deposition”


3

158/2020

Ghulam Muhammad Samiullah Asif. Pakistan.

“Engine based ranking machine for poultry sheds”


4

APPLICATION ACCEPTED

Notice is hereby given that the person interested in opposing the grant of Patents to any of the

applications referred to below at any time within four months from the date of this Patents’

journal may give notice at the Patent Office on the prescribed Form P-7 of the Patents Rules

18(1) of 2003.

The six figures number shown in the right hand side are those given to applications on

acceptance of the complete specification under which the specification will be printed and

subsequent proceeding taken.

The figures shown within square brackets after the title of inventions indicate their classification

index at acceptance.

Typed copies of the specification which are to open to public inspection can be supplied by the

Patent Office on payment of the prescribed charges which may be as certained on application to

the office.

1105/2009

SYNGENTA PARTICIPATIONS AG. Switzerland. and SYNGENTA LIMITED. United Kingdom.

“Carbonic acid ethyl ester 8-methoxy-l-methyl-2-oxo-

3-(2,4,6trimethyl-phenyl)-1,8-diaza-spiro[4.5]dec-3-en-

4-yI ester and its preparation”

A01N43/90, C07D471/10 & C07D 211/94.

143454

A compound of the formula I

wherein

X , Y and Z independently of each other are C1-

4alkyl, C3-6cycIoalkyl, C1-4haIoalkyl, C1-4aIkoxy,

halogen, phenyl or phenyl substituted by C1-

4alkyl, C1-4haloalkyl, halogen or cyano; m and n,

independently of each other, are 0, 1, 2 or 3 and

m+n is 0, 1, 2 or 3; G is hydrogen, a metal,

ammonium, sulfonium or a latentiating group; R

is hydrogen, C1-6alkyl, C1-6haloalkyl, C1-

6cyanoalkyl, benzyl, C1-4alkoxy(C1-4)alkyI, C1-


5

4alkoxy(C1-4)alkoxy(C1-4)alkyl or a group selected

from G; and A is C1-6alkyl, C1-6haloalkyl, C3-

6cycloalkyl, C3-6cycloalkyl(C1-4)alkyl, or C3-

6cycloalkyl(C1-4)alkyl where in the cycloalkyl

moiety a methylene group is replaced by O,S or

NR0, where R0 is C1-6alkyl or C1-6alkoxy, or A is

C2-6alkenyl, C2-6haloalkenyl, C3-6alkynyl, C1-

6cyanoalkyl, benzyl, C1-4alkoxy(C1-4)alkyl, C1-

4alkoxy(C1-4)alkoxy(C1-4)alkyl, oxetanyl,

tetrahydrofuranyl, tetrahydropyranyl, C1-

6alkylcarbonyl, C1-6alkoxycarbonyl, C3-

6cycloalkyl carbonyl, N-di(C1-6alkyl)carbamoyl,

benzoyl, C1-6alkylsulfonyl, phenylsulfonyl, C1-

4alkylthio(C1-4)alkyl, C1-4alkylsulfinyl(C1-4)alkyl

or C1-4alkylsulfonyl(C1-4)alkyl; which are useful

as pesticides, and their preparation.

998/2010

BARRICK GOLD CORPORATION. Canada.

“SEPARATION OF COPPER MINERALS FROM PYRITE USING AIR-METABISULFITE TREATMENT”

B03D1/12 & B03D1/02.

143455

The present invention provides a process for

recovering one or more metals, comprising:

providing a slurried valuable metal-containing

feed material comprising at least one of a copper

sulfide and molybdenum sulfide mineral as a

valuable metal sulfide mineral, wherein the

slurried valuable metal-containing feed material

comprises one or more of brackish water and salt

water having one or more of a salinity of about

0.01 % or more and a total dissolved solids of at

least about 10,000 mg/L and a gangue sulfide

mineral comprising iron pyrite;

aerating, with a molecular oxygen-containing gas,

the slurried valuable metal-containing feed

material to form an aerated slurried feed material;

thereafter contacting the aerated slurried feed

material, in the presence of at least about 3 ppm

of dissolved molecular oxygen, with a sulfoxy

reagent to form a treated slurried feed material;

and


6

floating the treated slurried feed material to form

a concentrate comprising at least most of the at

least one of a copper sulfide and molybdenum

sulfide mineral in the aerated slurried feed

material and tailings comprising the gangue

sulfide mineral in the aerated slurried feed

material.

84/2012

Lucite International UK Ltd. United Kingdom.

“A PROCESS FOR THE PRODUCTION OF (METH)ACRYLIC AND EASTER, AMIDES AND ANHYDRIDES THEREOF” C07C51/38, C07C67/08 & C08F20/02.

143456

A method of extracting (meth)acrylic acid from

an aqueous reaction medium into an organic

phase in contact therewith is described. The

aqueous reaction medium is formed from at least

one base catalyst and at least one dicarboxylic

acid selected from maleic, fumaric, malic,

itaconic, citraconic, mesaconic, and citramalic

acid or mixtures thereof in aqueous solution and

contains the base catalysed decarboxylation

products of the base catalysed reaction. The

method includes either the addition of at least one


7

of the said dicarboxylic acids and/or a precursor

thereof to the aqueous reaction medium to

enhance the solvent extraction of the

(meth)acrylic acid into the organic solvent or

maintaining the level of base catalyst to

dicarboxylic acid and/or pre-cursor at a

substoichiometric level during the extraction

process. The method extends to a process of

producing (meth)acrylic acid, its esters and

polymers and copolymers thereof.

667/2012

Respivert Limited. United Kingdom.

“1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(4-(2-(phenylamino)pyrimidin-4-yloxy)naphthalen-1-yl)urea for use as an inhibitor of p38 mitogen-activated protein kinase enzyme” C07D403/12, A61K31/4155 & A61K31/506.

143457

The present invention relates to a compound of

formula (I)

which is an inhibitor of the family of p38

mitogen-activated protein kinase enzyme, and to

its use in therapy, including in pharmaceutical

combination, especially in the treatment of

inflammatory diseases, including inflammatory

diseases of the lung, such as asthma and

COPD.(Chronic obstructive pulmonary disease).

793/2012

SICPA HOLDING SA. Switzerland.

“METHOD AND SYSTEM FOR CONTROLLING ITEMS ON A PRODUCTION/DISTRIBUTION LINE”

143458


8

The disclosed method, and corresponding system,

for controlling items on a production/distribution

line relies on secure identification of items

transported arranged according a given

disposition along a transport path at different sites

of the line and checking operation according to a

protocol which allows reducing processing load

while ensuring high reliability.

87/2013

SYNGENTA PARTICIPATIONS AG. Switzerland.

“PROCESS FOR THE STEREOSELECTIVE PREPARATION OF A PYRAZOLE CARBOXAMIDE” C07D231/14.

143459

The present invention relates to a process for the

enantioselective preparation of 3-difluoromethyl-

1-methyl-1H-pyrazole-4-carboxylic acid

((1S,4R)-9-dichloromethylene-1,2,3,4-

tetrahydro-1,4-methano-naphthalen-5-yl)-amide

of formula Ib.


9

205/2013

Monsanto Technology LLC. U.S.A.

“AN ENGINEERED HEMIPTERAN TOXIC PROTEIN (eHTP)” A01N63/02, C07K14/435 & C12N15/82.

143460

The present invention discloses an engineered

Hemipteran toxin protein (eHTP) engineered from

a scaffold toxin protein, wherein said eHTP

exhibits Hemipteran insect species inhibitory

activity against a Hemipteran pest species that is

from about 2 to about 260 times greater than the

Hemipteran inhibitory activity of said scaffold

toxin protein. Also disclosed are method of using

such protein, nucleotide sequences encoding such

protein, method of detecting and isolating such

protein, and their application in agricultural

systems.

598/2013

LOESCHE GmbH. Germany.

“An improved method for processing steel slag to produce a Hydraulic mineral binder” C04B 5/06 & C21C5/36.

143461

The invention relates to a method for processing

steel slag to produce a hydraulic mineral binder

with a high hardening potential and to recover

iron. There is provision for this purpose to

provide a feed product comprising steel slag with

MnO. This feed product is further processed as a

melt by introducing reducing agent into the melt.

A lime saturation factor of between 90 and 110 is

hereby to be achieved in the mineral melt portion.

Subsequently the melt is cooled in a defined

manner and elementary iron is mechanically

separated from the solidified melt. The solidified

melt is then supplied for use as hydraulic mineral

binder. Furthermore the invention relates to a

hydraulic mineral binder.


10

775/2013

INDUSTRIE DE NORA S.p.A. Italy.

“Cathode for evolution of hydrogen in industrial electrolytic processes and a method for its production”

C25B 9/20 & C25B11/04.

143462

The invention relates to an electrode suitable for

use as a cathode for hydrogen evolution in

industrial electrolytic processes. The electrode

comprises a metallic substrate, an internal

catalytic layer containing rhodium and an external

catalytic layer containing ruthenium.

797/2013

SANOFI. France.

“ANTI-CEACAM5 ANTIBODY AND PHARMACEUTICAL COMPOSITION THEREOF. C07K16/30 , A61K47/48 & A 61K 31/357.

143463

The present invention provides an antibody which

binds to A3-B3 domain of human

and Macaca fascicularis CEACAM5 proteins, as

well as isolated nucleic acids, vectors and host

cells comprising a sequence encoding said

antibody. The invention also discloses

immunoconjugate comprising said antibodies

conjugated or linked to a growth-inhibitory agent,

and pharmaceutical composition comprising

antibody, or immunoconjugate of the invention.

The antibody or immunoconjugate of the

invention are useful for the treatment of cancer or

for diagnostic purposes.


11

364/2014

Alim-un-Nisa, Dr. M. Khalid Saeed, Sajila Hina, Naseem Zahra, Dr. Imran Kalim, Dr. Shahid Masood, Dr. Ijaz Ahmad, Dr. Qurat-ul-Ain Syed, Dr. Sakhawat Ali & Dr. Shahzad Alam Pakistan.

“NATURAL WATER SOLUBLE RED DYE IN PASTE FORM PREPARED FROM RED BEET ROOTS (BETA VULGARIS)”

A01N1/02, G01K11/12 & G01K11/06.

143464

The invention provides novel natural water

soluble red dye prepared from red beet roots (Beta

vulgaris) in paste form involving no hazardous

chemicals. The uniqueness of prepared red dye is

that it is simply prepared in water having no use

of alcohol or any other harmful solvents. The

prepared red dye paste is highly stable in

refrigerator at a temperature range of 2-7 °C for 1

year and at room temperature ranged from 20-25

°C is of 90 days. The developed red dye belongs

to betanins family containing food grade

stabilizers of potential inhibitory effects. These

compounds in an effective amount restrain the

fading of color under different thermal variations.

This water soluble red dye in paste form is best

natural alternative of synthetic harmful dyes

prepared from indigenous cheap source. The

present natural red dye will be an effective and

healthier alternative of F. D. & C. # 2 (Amaranth)

and F. D. & C. # 40 (Allura red) because it is non-

toxic, non-allergic and environment friendly. The

present natural red food dye has so many

industrial applications as it may have its best use

in baked foods, frozen products, candies, jams,

beverages, desserts, confectioneries, gelatins,

dairy and meat goods. It has potential

antibacterial, antifungal and antioxidant activity

which increase product integrity.

741/2014

CHIESI FARMACEUTICI S.p.A. Italy.

“Process for the preparation of 1-(3-(cyclopropylmethoxy)-4-(difluoromethoxy)phenyl)-2-(3,5-dichloro-1-pyridin-4-yl)ethanone”

C07D213/89 & C07D213/61.

143465


12

The present invention relates to a process for the

preparation of compounds endowed with

phosphodiesterase (PDE4) inhibitory activity

having formula (I). The invention also relates to

the process for the isolation by crystallization of

the compound (I) and to its use for the preparation

of pharmaceutical compositions for inhalation in

combination with suitable carriers or vehicles.

The present invention also relates to solvates and

crystal forms of a compound of formula (I). The

synthesized product is suitable for use in

pharmaceutical applications for instance in the

treatment of respiratory diseases.

882/2014

SICPA HOLDING SA, Switzerland.

“MARKING COMPRISING TWO PATTERNS ON A SURFACE, METHOD AND SYSTEM FOR APPLYING A MARKING ON A SURFACE”

G06K19/08 & G06K19/06.

143466

Marking comprising on a surface:

- a first pattern for coding a first numerical

information item on said surface, the first pattern

comprising a specific arrangement of a plurality

of symbols belonging to a set of symbols, each

symbol in the arrangement being intended for the

coding of a portion of said numerical information

item, each symbol including at least one

differential pair of elements positioned in a

specific way, each element having a parameter,

the parameter of the first element of each

differential pair having a first value and the

parameter of the second element of each

differential pair having a second value different

from the first value,

- a second pattern for coding a second numerical

information item on said surface, wherein the first

and second pattern are adapted to be read under

corresponding distinct first and second reading

conditions.


13

274/2015

DOW AGROSCIENCES LLC. U.S.A.

“PESTICIDAL COMPOSITION COMPRISING PYRAZOLO [3,4-C]PIPERIDIN-2-ONE” A01N27/00, A01N47/02, A01N43/90, C07D47/04 & A01N37/20.

143467

This document discloses molecule having the

following formula I, or any agriculturally

acceptable salt thereof,

wherein

R1, R

2, R

3, R

4, R

5, R

6, R

7, R

8, R

9, X

1, Q, and n are

as described herein;

This disclosure relates to the field of molecule

having pesticidal utility against pests in Phyla

Arthropoda, Mollusca, and Nematoda. These


14

pesticidal composition may be used, for example,

as acaricides, insecticides, miticides,

molluscicides, and nematicides.

442/2015

Novartis AG. Switzerland.

“Pharmaceutical dosage form comprising the drug substance 4-[(5R)-6,7-dihydro-5H-pyrrolo [1,2-c] imidazol-5-yl] -3-fluorobenzonitrile and microcrystalline cellulose” A61K9/20 & A61K31/45.

143468

The present invention relates to a pharmaceutical

dosage form for oral administration comprising

(a) the drug substance 4-[(5R)-6,7-

dihydro-5H-pyrrolo [1,2-c] imidazol-5-yl] -3-

fluorobenzonitrile as defined by formula (I)

or any pharmaceutically acceptable salt thereof,

and

(b) at least 30% by weight of microcrystalline

cellulose based on the total weight of said

pharmaceutical dosage form.

The present invention further provides a process

for the preparation of a pharmaceutical dosage

form comprising blending the drug substance 4-

[(5R)-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-

yl]-3-fluorobenzonitrile with microcrystalline

cellulose. The pharmaceutical dosage form of

present invention is useful to treat Cusing's

disease or Cushing's syndrome.

591/2015

DOW AGROSCIENCES LLC. U.S.A.

“HERBICIDAL COMPOSITION COMNPRISING PYRIDINE CARBOXYLIC ACID AND AN


15

ACETOLACTATE SYNTHASE (ALS) INHIBITOR”

A01N43/40, A01N47/36 & A01N43/653.

143469

Disclosed herein are herbicidal composition

comprising a herbicidally effective amount of (a)

a pyridine carboxylic acid herbicide can comprise

compound defined by Formula (I)

wherein

X, R1, R

2, R

3, R

4, A, N, O are as defined herein,

or an agriculturally acceptable N- oxide, salt, or

ester thereof, and (b) an acetolactate synthase

(ALS) inhibitor or an agriculturally acceptable

salt or ester thereof. Also disclosed herein are

method of controlling undesirable vegetation

which comprise applying to vegetation or an area

adjacent the vegetation or applying to soil or

water to prevent the emergence or growth of

vegetation (a) a pyridine carboxylic acid herbicide

or an agriculturally acceptable N-oxide, salt, or

ester thereof, and (b) an acetolactate synthase

(ALS) inhibitor or an agriculturally acceptable

salt or ester thereof, wherein (a) and (b) are each

added in an amount sufficient to provide a

herbicidal effect.

834/2016

CRRC Shandong Co., Ltd. Peoples China.

“SELF-GENERATING CAST STEEL THREE-PIECE BOGIE” B61F5/50.

143470

Provided is a self-generating cast steel three-piece

bogie, including a wheelset I, a wheelset II, a side

frame assembly, a suspension damping device, a


16

bolster assembly, a foundation brake rigging, a

bearing and side bearing, a cantilever beam

assembly, and a shaft end power generation

device; wherein a shaft-extension is disposed at

an outer end of a journal of the wheelset I, and a

vertically installed base plate is disposed at an end

of the side frame assembly close to the wheelset I;

the cantilever beam assembly includes an upper

cover plate, an end plate, a lifting lug vertical

plate and an adjusting lead screw fixing seat, and

the cantilever beam assembly is connected to the

side frame assembly via the end plate and the

vertically installed base plate; the shaft end power

generation device includes a generator, a tension

device and a shaft end transmission device,

wherein the generator is hung on the lifting lug

vertical plate of the cantilever beam assembly, the

tension device is mounted on the adjusting lead

screw fixing seat of the cantilever beam assembly,

and a belt pulley of the shaft end transmission

device is mounted on the shaft-extension of

wheelset I. The present invention is applied to the

cast steel three-piece bogie, hereby ensuring

vehicle self-generating reliability and possessing a

good economy.

139/2017

HONDA MOTOR CO., LTD. Japan.

“INTERNAL COMBUSTION ENGINE” F02B63/04,F02B67/06 & F16H 7/12.


17

143471

[Problem] In an internal combustion engine, to

secure a separator member and a cam chain guide

with a simple structure. [Solution] In an internal

combustion engine including a cam chain

chamber 73 at which a cam chain 72 that turns a

cam gear 70 of a camshaft 67 is disposed and a

generator chamber 45 at which a turning member

56 that turns with a crankshaft 30 is disposed, a

separator member 80 that divides the cam chain

chamber 73 and the generator chamber 45

includes securing portions 84a and 84b secured to

a one-side crankcase 40a of the cam chain

chamber 73, and the securing portions 84a and

84b of the separator member 80 are disposed at

the one-side crankcase 40a coaxially with a cam

chain tensioner member 92 that guides the cam

chain 72.

318/2018

ELI LILLY AND COMPANY. U.S.A.

“ANTIBODY THAT BINDS TO BTLA (B AND T LYMPHOCYTE ATTENUATOR) AND PHARMACEUTICAL COMPOSITION THEREOF” C07K16/28.


18

143472

The present invention provides an antibody that

binds BTLA, comprising HCDR1 having the

amino acid sequence of SEQ ID NO: 13, HCDR2

having the amino acid sequence of SEQ ID NO:

16, HCDR3 having the amino acid sequence of

SEQ ID NO: 19, LCDR1 having the amino acid

sequence of SEQ ID NO: 22, LCDR2 having the

amino acid sequence of SEQ ID NO: 25, and

LCDR3 having the amino acid sequence of SEQ

ID NO: 28. The present invention also provides

an antibody that binds BTLA, comprising

HCDR1 having the amino acid sequence of SEQ

ID NO: 14, HCDR2 having the amino acid

sequence of SEQ ID NO: 17, HCDR3 having the

amino acid sequence of SEQ ID NO: 20, LCDR1

having the amino acid sequence of SEQ ID NO:

23, LCDR2 having the amino acid sequence of

SEQ ID NO: 26, and LCDR3 having the amino

acid sequence of SEQ ID NO: 29. The present

invention further provides an antibody that binds

BTLA, comprising HCDR1 having the amino

acid sequence of SEQ ID NO: 15, HCDR2 having

the amino acid sequence of SEQ ID NO: 18,

HCDR3 having the amino acid sequence of SEQ

ID NO: 21, LCDR1 having the amino acid

sequence of SEQ ID NO: 24, LCDR2 having the

amino acid sequence of SEQ ID NO: 27, and

LCDR3 having the amino acid sequence of SEQ

ID NO: 30. The antibody of invention is

therapeutically effective for treating conditions

associated with autoimmune disease including

treating lupus. 61/2019

Zabta Khan Shinwari, Safia Hameed, Ali Talha Khalil and Muhammad Ali. Pakistan.

“Synthesis of zinc oxide nanorods using Momordica charantia plant extracts” B82Y30/00, C09C1/043, C03C2217/216 & Y10S977/773.

143473

A method for the synthesis of Zinc oxide

nanorods susing green synthesis method and

calcination at 500°C using Momordica charantia


19

as ecofriendly and Iow cost reducing agent is

disclosed. The extracts are aqueous, while zinc

acetate (ZnC4H6O4) is used as a precursor and can

be added directly. ZnO nanorods can be produced

using extracts of Momordica charantia and zinc

acetate precursor salt by providing suitable

conditions. Figure 1: Schematic indicating

different steps of the fabrication of ZnO nanorods

using Momordica charantia.

49/2020

BARRICK GOLD CORPORATION. Canada.

“SEPARATION OF COPPER MINERALS FROM PYRITE USING AIR-METABISULFITE TREATMENT” B03D1/08, B03D1/12 & C22B15/00.

143474

The present invention provides a process for

recovering one or more metals, comprising:

providing an oxygenated, slurried valuable metal-

containing feed material comprising a valuable

metal sulfide mineral, wherein the oxygenated,

slurried valuable metal-containing feed material

comprises one or more of brackish water having a

salinity of about 0.1 parts per thousand (0.01%) or

more, saltwater having a salinity of about 0.1

parts per thousand (0.01%) or more, fresh water

having a salinity of about 0.1 parts per thousand


20

(0.01%) or more, and buffered water having a

salinity of about 0.1 parts per thousand (0.01%) or

more, and a gangue sulfide mineral comprising

iron pyrite; and

contacting the oxygenated, slurried valuable

metal-containing feed material, while maintaining

the dissolved oxygen content of the oxygenated,

slurried valuable metal-containing feed material at

a level of at least about 3 ppm, with a sulfoxy

reagent to form a treated slurried feed material;

and

floating the treated slurried feed material to form

a concentrate comprising the valuable metal

sulfide mineral and tailings comprising the iron

pyrite.


21

SEALING FEES DUE

Notice is hereby given that the Patent may now be sealed on the application referred to below if

it is desired that Patent should be sealed a request on the prescribed Form-10 accompanied by the

fee of Rs.6750/- should be sent to the Controller of Patents and Designs, The Patent Office,

Karachi.

Accepted

No.

Applicant Name Application

No.

143329

JANSSEN SCIENCES IRELAND UC, Ireland.

530/2012

143330

Sanofi. France.

149/2013

143331

Dr. Murtaza Najabat Ali & Zainab Munib. Pakistan.

77/2014

143332

Regeneron Pharmaceuticals, Inc. U.S.A.

171/2014

143333


779/2014

143334

Amjad Qayyum Babar. Pakistan.

127/2017

143335

OPULENT ELECTRONICS INTERNATIONAL PTE. LTD. Singapore.

547/2018

143336

BECTON DICKINSON FRANCE. France.

520/2013

143337

ASAHI GROUP HOLDINGS, LTD. Japan.

11/2016

143338

GlaxoSmithKline Intellectual Property Development Limited and University of Dundee. United Kingdom.

40/2016

143339

Shah Technologies LLC. U.S.A.

186/2017

143340

GASFRAC ENERGY SERVICES INC. Canada.

678/2011

143341 Sumitomo Chemical Company, Limited.


22

Japan.

189/2012

143342

Radionor Communications AS. Norway.

306/2012

143343

ARAGON PHARMACEUTICALS, INC., U.S.A.

19/2014

143344


560/2015

143345

ARAGON PHARMACEUTICALS, INC. U.S.A.

703/2019

143346

Zoya Tariq & Dr. Zubaida Yousaf. Pakistan.

207/2015

143347

LONATI S.P.A., Italy.

683/2015

143348


319/2016

143349

Muhammad Uzair Qamar; Muhammad Nabeel; Mohsin ijaz.; Siraj Yousaf; Fouzia Anwar ; Hasnain Mehdi Jafri; Muhammad Azmat and Muhammad Adnan Shahid. Pakistan.

121/2017

143350

Enanta Pharmaceuticals, Inc. U.S.A.

683/2011

143351

Stora Enso Oyj. Finland.

157/2013

143352


375/2013

143353

GlaxoSmithKline Intellectual Property (No.2) Limited. United Kingdom.

476/2013

143354


94/2014

143355


305/2015

143356


523/2016

143357 Erber Aktiengesellschaft. Austria.

485/2017


23

143358

Mr. Arish Rvaan Malik. Pakistan.

515/2017

143359


326/2018

143360

Enanta Pharmaceuticals, Inc. U.S.A.

649/2019

143361

Galapagos NV. Belgium.

870/2012

143362

Genzyme Corporation. U.S.A.

27/2013

143363

Groz-Beckert KG, Germany.

186/2015

143364

Trutzschler GmbH & Co. KG. Germany.

189/2015

143365

HANMI PHARM. CO., LTD., Rep.of Korea.

416/2015

143366

VIIV Healthcare UK LIMITED. Great Britain.

438/2015

143367


613/2015

143368

SAINT-GOBAIN PLACO; SAINT-GOBAIN ISOVER and CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE. France.

642/2015

143369

British American Tobacco (Investments) Limited. United Kingdom.

778/2015

143370

Steven Caffall Finch. United Kingdom.

200/2016

143371


308/2017

143372

QINGDAO HAIER AIR CONDITIONER GENERAL CORP., LTD. China.

551/2017

143373

NOVARTIS AG and Debiopharm S.A. Switzerland.

895/2011

143374

KSB Aktiengesellschaft. Germany.

377/2012


24

143375

DyStar Colours Distribution GmbH. Germany.

726/2013

143376

F. HOFFMANN-LA ROCHE AG. Switzerland.

414/2015

143377

DCM Shriram Ltd., India.

514/2015

143378

Gilead Sciences, Inc., U.S.A.

684/2015

143379

LONATI S.P.A., Italy

75/2016

143380

SYED MOHSIN ALI; SYED BURHANUDDIN ABDALI; Z.A.DHAKAN and MUHAMMAD ADIL. Pakistan.

568/2008

143381

BOEHRINGER INGELHEIM INTERNATIONAL GmbH. Germany.

511/2012

143382

REGULUS THERAPEUTICS INC. U.S.A.

685/2013

143383

MIDREX TECHNOLOGIES, INC. U.S.A.

919/2013

143384

PFIZER INC. U.S.A.

99/2014

143385

CJ CHEILJEDANG CORPORATION. Rep.of Korea

120/2014

143386

SAIPEM S.p.A. Italy.

391/2014

143387

FMC Corporation, U.S.A.

519/2014

143388


887/2014

143389


890/2014

143390

SAINT-GOBAIN PLACO. France.

2/2015

143391


4/2015

143392 Chiesi Farmaceutici S.p.A., Italy.

417/2015


25

143393

Tata Consultancy Services Limited. India.

98/2017

143394

Muhammad Kamil, Samina Iqbal, Kamran Abro, Sofia Khalique Alvi , Shagufta Shaikh , Ghulam Fareed, Sheraz Shafiq and Alia Bano Munshi. Pakistan.

686/2017

143395

MITSUBISHI HEAVY INDUSTRIES, LTD. Japan.

643/2010

143396

Monsanto Technology LLC. U.S.A.

398/2011

143397


674/2011

143398

INDUSTRIE DE NORA S.p.A. Italy.

689/2013

143399

LES LABORATOIRES SERVIER. France.

846/2013

143400

NOVARTIS AG. Switzerland.

791/2014

143401


23/2016

143402

Air and Space Defence Corporation <<Almaz - Antey>> Russian Federation.

644/2017

143403

YKK CORPORATION. Japan.

707/2018

143404

CHIESI FARMACEUTICI S.p.A. Italy.

565/2011

143405

SICPA HOLDING SA. Switzerland.

875/2011

143406

RIETER INGOLSTADT GMBH. Germany.

644/2014

143407

OTSUKA PHARMACEUTICAL FACTORY, INC. Japan.

1/2015

143408

INEOS TECHNOLOGIES SA. Switzerland.

674/2015


26

143409

British American Tobacco (Investments) Limited. United Kingdom.

788/2015


27

NEW APPLICATIONS FOR THE INDUSTRIAL DESIGNS

S. No. Design

No. Title & Class Applicant

02/03/2020

1. 20354 Boat (Class-03) Muhammad Abbas, trading as TFG

Boat Yard,

2. 20355 Boat (Class-03) Muhammad Abbas trading as TFG

Boat Yard,


Boat Yard,


Boat Yard,

05/03/2020

5. 20358 QUALITY SENSOR (CLASS-NILL) Saurer Technologies GmbH & Co.

KG

06/03/2020

6. 20359 Smart Geyser (Class 12) PC ENGINNERS TRADING AS

SAVER STAR

7. 20360 BED, TABLE TOP, DOOR (Class 3) ABBAS ALI S/O MANZOOR

AHMED


28

REGISTRATION OF DESIGNS

The following designs have been registered.

S. No. Design

No. Title & Class Applicant

04/03/2020

1. 18916 a watch movement (Class-01) LVMH Swiss Manufactures SA (Swiss

Company)

2. 18917 a watch movement (Class-01) LVMH Swiss Manufactures SA (Swiss

Company)

-sd-

(Dr. Muhammad Fayyaz Ahmad)

Controller of Patents

& Registrar of Designs

Ph: 99230591

Documents

Weekending:- 06-03-2020 Legal Publication Date:- 09-07 ... · Legal Publication Date:- 09-07-2020 Journal Code (200709) Patents’ journal 09-07-2020 1 NEW APPLICATIONS FOR THE PATENTS